Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.19 by 54.26 percent. This is a 9.38 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $194.430 million which missed the analyst consensus estimate of $199.395 million by 2.49 percent. This is a 18.72 percent increase over sales of $163.769 million the same period last year.